Feature | ASTRO | September 23, 2019

Top Radiation Oncology Research and Clinical Trials at ASTRO 2019

ASTRO highlights top-rated abstract presentations at its annual meeting

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced the top-rated studies being highlighted at the 2019 ASTRO Annual Meeting, Sept. 15 - 18 in Chicago. These presentations are being highlighted with press conferences.

Presentations Sunday, Sept. 15:

   • Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial, presented by Daniel Spratt, University of Michigan Rogel Cancer Center (Abstract LBA-1)

   • Primary Outcomes of a Phase II Randomized Trial of Observation versus Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE), presented by  Ryan Phillips, Johns Hopkins Kimmel Cancer Center (Abstract LBA-3)

   • Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial, presented by Julia White, The Ohio State University Comprehensive Cancer Center (Abstract 5)

   • Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT)," presented by  Clifford Robinson, Washington University School of Medicine in St. Louis (Abstract LBA-4)

Presentations Monday, Sept. 16:

   • Final Results of a Phase II Prospective Trial Evaluating the Combination of Stereotactic Body Radiotherapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), presented by Allison Campbell, Yale Cancer Center (Abstract 74)

   • Patterns of Disease Progression with Durvalumab in Stage III NSCLC (PACIFIC), presented by Andreas Rimner, Memorial Sloan Kettering Cancer Center (Abstract LBA-6)

   • Applying a Machine Learning Approach to Predict Acute Radiation Toxicities for Head and Neck Cancer Patients, presented by Jay P. Reddy, The University of Texas MD Anderson Cancer Center (Abstract 141)

   • The Impact of the Closure of Women’s Health Clinics on Cervical Cancer in the United States, presented by Amar Srivastava, Washington University School of Medicine in St. Louis (Abstract 202)

The 2019 ASTRO Annual Meeting is expected to attract more than 10,000 oncologists, clinicians, researchers and other healthcare professionals from across the globe. Throughout the four-day meeting, researchers will present peer-reviewed abstracts on advances in clinical care for cancer patients, while panels and interactive case discussions featuring leading experts will underscore the meeting’s theme, “Innovate, Collaborate: Transform.”

 

ASTRO 2019 Video Interviews:

VIDEO: Artificial Intelligence Driven Adaptive Radiotherapy System Begins Treating Patients — Interview with David Sjostrom, Ph.D.

VIDEO: Clinical and Physics Aspects of Re-irradiation of Previously Treated Radiotherapy Tumor Sites — Interview with Kristin Higgins, M.D.

VIDEO: Cardiac Radiotherapy Ablation to Treat Ventricular Tachycardia — Interview with Clifford Robinson, M.D.

VIDEO: Understanding the Radiation Oncology Alternative Payment Model — Interview with Anne Hubbard, MBA, ASTRO

VIDEO: Preserving Neurocognitive Function During Whole-Brain Radiotherapy — Interview with Vinai Gondi, M.D.

VIDEO: Palliative Radiation Oncology For Patients Who Need Symptom Relief — Interview with Candice Johnstone, M.D.

VIDEO: Use of Hydrogel to Reduce Rectal Toxicity for Prostate Radiotherapy — Interview with Bill Hartsell, M.D.

VIDEO: Integration of Advanced Practice Providers in Radiation Oncology — Interview with Lorraine Drapek, DNP

 

Late-breaking Radiation Therapy Clinical Trials at ASTRO 2018

Find more news and video from ASTRO

 

Related Content

MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier
Image by Kira Hoffmann from Pixabay  #RSNA19

Image by Kira Hoffmann from Pixabay 

News | Clinical Trials | November 30, 2019
November 30, 2019 — Researchers are trying to identify injury patterns and predict future outcomes for victims of gun
This bar graph shows breast cancer presentation by screening interval #RSNA19

This bar graph shows breast cancer presentation by screening interval. Image courtesy of study author and RSNA

News | Breast Imaging | November 28, 2019
November 28, 2019 — Cancers found in patients undergoing annual...
Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
November 28, 2019 — Reports of new cancer treatments
Reduction in fractional anisotropy (FA) in obese patients compared to the control group

Reduction in fractional anisotropy (FA) in obese patients compared to the control group: At the intersection of the alignment vectors, a large cluster of FA decrease located in the corpus callosum on the left. In red: Reduction of FA in obese patients compared to controls, and FA skeleton (green), superimposed on the mean of FA images in sample. Image courtesy of Pamela Bertolazzi, Ph.D., and RSNA.

News | Clinical Trials | November 25, 2019
November 25, 2019 — Researchers using magn...
FerrAlert technology automatically detects and logs ferromagnetic events and exclusively provides a photographic stream which is date and time stamped
News | Magnetic Resonance Imaging (MRI) | November 22, 2019
November 22, 2019 — Kopp Development Inc. acquired Mednovus, Inc.
One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice
News | Clinical Trials | November 21, 2019
November 21, 2019 — One in three adults treated for cancer may experience side effects from treatment they wish they